Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

News briefs

- Featured Image

CSIRO finds new way to harvest stem cells

Scientists at the CSIRO have found a new way to harvest stem cells which reduces the time required to obtain adequate numbers of cells, without the need for a growth factor, according to research published in Nature Communications. “Current harvesting methods take a long time and require injections of a growth factor to boost stem cell numbers. This often leads to side effects. The method … combines a newly discovered molecule (known as BOP), with an existing type of molecule (AMD3100) to mobilise the stem cells found in bone marrow out into the bloodstream. Combining the two molecules directly impacts stem cells so they can be seen in the blood stream within an hour of a single dosage.” The researchers also found that “when the harvested cells are transplanted they can replenish the entire bone marrow system, and there are no known side effects”. The next step is a Phase I clinical trial assessing the combination of BOP molecule with the growth factor, prior to the eventual successful combination of the two small molecules BOP and AMD3100. The research was done in collaboration with the Australian Regenerative Medicine Institute at Monash University.

Trial deaths spark idelalisib safety warning

The Therapeutic Drugs by Administration (TGA) is reviewing information provided the manufacturers of cancer drug…

email